"Write a 2 page (minimum - feel free to write more!) position statement (see more about "position statements/papers" below) on the topic of D2C (Direct to Consumer) Pharmaceutical Advertising. Spend s

Sample Outline

I. Introduction 
___A. Introduce the topic 
___B. Provide background on the topic to explain why it is important
___C. Assert the thesis (your view of the issue). More on thesis statements can be found below.

Your introduction has a dual purpose: to indicate both the topic and your approach to it (your thesis statement), and to arouse your reader’s interest in what you have to say. One effective way of introducing a topic is to place it in context – to supply a kind of backdrop that will put it in perspective. You should discuss the area into which your topic fits, and then gradually lead into your specific field of discussion (re: your thesis statement).

II. Counter Argument 
___A. Summarize the counterclaims 
___B. Provide supporting information for counterclaims 
___C. Refute the counterclaims 
___D. Give evidence for argument

III. Your Argument 
___A. Assert point #1 of your claims 
_____1. Give your educated and informed opinion 
_____2. Provide support/proof using more than one source (preferably three) 
___B. Assert point #2 of your claims 
_____1. Give your educated and informed opinion 
_____2. Provide support/proof using more than one source (preferably three) 
___C. Assert point #3 of your claims 
_____1. Give your educated and informed opinion 
_____2. Provide support/proof using more than one source (preferably three)

You may have more than 3 overall points to your argument, but you should not have fewer.

IV. Conclusion 
___A. Restate your argument 
___B. Provide a plan of action but do not introduce new information

The simplest and most basic conclusion is one that restates the thesis in different words and then discusses its implications.

Taken from http://www.sfu.ca/cmns/130d1/WritingaPositionPaper.htm

here is the opening paragraph, pls use it:

Currently, as stated by Ventola (2011), the United States and New Zealand are the only two countries in the world that allow Direct-to-Consumer Drug Advertising (DTCPA). Ventola (2011) provides the following definition of DTCPA: "an effort (usually via popular media) made by a pharmaceutical company to promote its prescription products directly to patients." However, this practice continues to receive its fair share of criticism.

that is the thesis statement

While there are several positive outcomes associated with DTCPA, including reduction of stigma, patient education, and improves quality of communication between patient and provider, these outcomes are still outweighed by the negative outcomes associated with DTCPA, including misleading the patient, lack of sufficient human trials to establish product safety, and increased medicalization and drug overuse due to the general public becoming overexposed to DTCPA.